Topics

Lung Cancer Corporate

07:43 EDT 20th September 2019 | BioPortfolio

Third Coast Therapeutics

Third Coast Therapeutics is a biotechnology company dedicated to developing orally active, small-molecule drugs that target the spread of cancer cells. Metastasis is estimated to cause 90 percent of cancer deaths. There are currently no approved drugs targeting this process. Third Coast’s lead candidate, 3crx98, is specifically designed to inhibit the movement of cancer cells without toxic s...

NOXXON Pharma N.V.

NOXXON’s oncology-focused pipeline acts on the tumor microenvironment (TME) and the cancer immunity cycle by breaking the tumor protection barrier and blocking tumor repair. By neutralizing chemokines in the tumor microenvironment, NOXXON’s approach works in combination with other forms of treatment to weaken tumor defenses against the immune system and enable greater therapeutic impact...

LumaCyte

LumaCyte produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labelling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate...

The Oncology Institute

Designed around the patient and rooted in evidence, The Oncology Institute of Hope & Innovation is the only national, physician-led provider delivering on the promise of value-based care. Through an ecosystem that fully integrates the cancer care team, from pre-diagnosis to end-of-life, The Oncology Institute brings quality care into the community setting. By partnering with health plans and inde...

Aleta Biotherapeutics

Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb, who bring extensive scientific and leadership experience in immunology, oncology and drug development to this new enterprise. Aleta has c...

National Ovarian Cancer Coalition

For more than 25 years, the National Ovarian Cancer Coalition has been committed to raising awareness, promoting education, and funding research in support of women, families and communities touched by ovarian cancer. The NOCC is an important national advocate for patients and families struggling with ovarian cancer, and remains steadfast in its mission “to save lives by fighting tirelessly ...

Oncternal Therapeutics, Inc.

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on developing a diverse pipeline of product candidates for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation and progression. The pipeline includes its lead clinical program, cirmtuzumab, a monoclonal...

Cancer Insight

Sensei Biotherapeutics, Inc.,

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies to transform the cancer treatment landscape. The company is using its proprietary drug discovery platform, called SPIRIT, to discover and develop both vaccines and T-cell therapies, including SNS-301, its clinical stage cancer vaccine, and SNS-723, its cell therapy program in precli...

CDISC and The Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double pancreatic can...

Israel-cancer-association-USA

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of small molecule drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across m...

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and proge...

Global Access to Cancer Care Foundation

The Global Access to Cancer Care Foundation (GACCF) offers training, technology, access, and hope; specifically, for low and middle-income countries (LMICs) in South America, Africa, South, and East Asia. The foundation’s cancer care professionals help to implement and oversee training courses and workshops in collaboration with local partners such as universities, hospitals or governmental ...

Cleave Therapeutics, Inc.

Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP), also known as p97, as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases. The privately held company, based in San Francisco, is advancing CB-5339, its second-generation, small molecule VCP/p97 inhibitor, to clinical studies i...

Onco360 Oncology Pharmacy

Onco360 is the largest independent Oncology Pharmacy and clinical support services company in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It disp...

Cancer Treatment Centers of America in Tulsa

“We are thrilled to welcome Dr. Kim to our team,” said Jay Foley, president and CEO of CTCA Tulsa. “He is a results-driven individual with a passion for innovative cancer care. Dr. Kim’s expertise will provide our patients with excellent options relating to head and neck oncology and maxillofacial reconstruction.”

Modra Pharmaceuticals B.V.

Modra Pharmaceuticals aims to re-define taxane chemotherapy by developing therapies that are less toxic, more effective and can be taken at home in tablet form. The Company’s goal is to radically improve the therapeutic outcomes and everyday lives of the hundreds of thousands of cancer patients undergoing taxane chemotherapy worldwide. Modra’s lead program is advancing into Phase 2 clin...

M2Gen

M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of precision medicine. M2Gen partners with the nation's leading cancer centers through the Oncology Research Information Exchange Network (ORIEN®) to implement the Total Cancer Care® (TCC) Protocol creating a large, cancer-focused data warehouse linking clinical and molecular data. Usin...

AgilVax Inc.

AgilVax is a biopharmaceutical company developing xCT antibody-based products to treat multiple types of cancer in combination with chemotherapy, checkpoint and KRAS inhibitors. The Company has two products in development; AX09, a VLP-based immunotherapeutic currently in cGMP production and targeted to begin human clinical trials for the treatment of metastatic colorectal cancer in the 2H 2020, a...

BostonGene Corporation

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics...

Stupid Cancer

Stupid Cancer, a 501(c)3 nonprofit organization, is the leader in young adult cancer advocacy, education, research, and support. Stupid Cancer’s mission is to end isolation, redefine community, provide education and support, and improve quality of life for the young adult cancer community.

Orum Therapeutics, Inc.

Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum...

Imugene Ltd

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and oth...

Silicon Therapeutics

Silicon Therapeutics (“SiTX”) is a physics-driven drug discovery company focused on small molecule therapeutics for cancer that target innate immunity to “light the spark” within immunologically cold tumors. The company’s unique computational physics-based platform can accurately simulate the physical motion and properties of biological targets at atomistic resolution to ...

Quick Search

review and buy Lung Cancer market research data and corporate reports here